What is the share price of Adinath Bio-Lab Ltd (590088)?

Company share prices are keep on changing according to the market conditions. The current trading price of Adinath Bio-Lab Ltd (590088) on 01-Jan-1970 05:30:00 at 05:30 is .

What is the P/E ratio of Adinath Bio-Lab?

The latest standalone P/E ratio of Adinath Bio-Lab as of 01-Jan-1970 is 0.00.

What is the P/B ratio of Adinath Bio-Lab Ltd (590088)?

The latest standalone P/B ratio of Adinath Bio-Lab Ltd (590088) as of 01-Jan-1970 is 0.23.

What is the 52-week high and low of Adinath Bio-Lab Ltd (590088)?

The 52-week high of Adinath Bio-Lab Ltd (590088) is Rs. 0.30 and the 52-week low is Rs. 0.30.

Adinath Bio-Lab Ltd (590088) Share Analysis – Quality, Valuation Zone & Price Trend & DeciZen Rating

Name: Adinath Bio-Lab Ltd (590088)
Brand: Adinath Bio-Lab

Adinath Bio-Lab Ltd (590088)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 590088 NSE: Trading | Small Cap | Adinath Bio-Lab Share Price

Adinath Bio-Lab Ltd (590088)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 590088 NSE: Trading | Small Cap | Adinath Bio-Lab Share Price

Key Metrics

Valuation Multiples

Market Cap

₹7 Cr.

Current Price

₹0

52-Week Low / High

₹0 / 0

TTM EPS

₹-0.1

TTM Sales

₹0 Cr.

Book Value per Share

₹1.3

P/E Ratio

0.00

Industry PE

Price to Book (P/B)

0.23

Price to Sales (P/S)

0.00

EV/EBITDA

-12.57

Dividend Yield

0.00%

Profitability Efficiency

Return on Equity (ROE)

-34.08%

Return on Capital Employed (ROCE)

-34.32%

Return on Assets (ROA)

-30.36%

Operating Profit Margin

Net Profit Margin

Gross Profit Margin

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Steady versus 3-year growth rate

-100%

Operating Profit Growth (1 Year)

Net Profit Growth (1 Year)

Asset Quality

Promoter Holding

25.75%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹7 Cr.

Equity

₹22.1 Cr.

Face Value

₹1

All Time Low / High

₹0.15 / 29.70

Adinath Bio-Lab stock performance

Key Ratios

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	TTM
ROCE % ⓘ	7.4%	3.2%	2.5%	2.4%	0.5%	0.6%	1%	0.2%	-52%	-34.3%	-
Value Creation Index ⓘ	-0.5	-0.8	-0.8	-0.8	-1.0	-1.0	-0.9	-1.0	-4.7	-3.5	-
Growth Parameters ⓘ
Sales ⓘ	32.5	56.5	42.2	42.9	1	1.4	0.8	0.6	0.1	0	0
Sales YoY Gr.	-	73.7%	-25.3%	1.6%	-97.7%	35%	-40%	-30.9%	-91.1%	-100%	-
Adj EPS ⓘ	0.1	0	0	0	0	0	0	0	-0.3	-0.1	-0.1
YoY Gr.	-	-55.6%	-25%	0%	-66.7%	0%	-100%	NA	NA	NA	-
BVPS (₹) ⓘ	1.2	1.3	1.3	1.3	1.3	1.3	1.3	0.7	0.4	0.3	1.3
Adj Net Profit ⓘ	1.9	0.9	0.7	0.7	0.1	0.2	0	0	-5.7	-2.5	-2
Cash Flow from Ops. ⓘ	1.1	-1.4	-1.3	-0.1	-0.1	-0.1	-2.6	0.1	-0.5	-0	-
Debt/CF from Ops. ⓘ	0	0	0	0	0	0	0	0	0	0	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	-100%	-100%	-100%	-100%
Adj EPS ⓘ	-202.3%	-261.5%	NA	NA
BVPSⓘ	-15%	-26.7%	-40.5%	-28.2%
Share Price	-	-	-	-

Key Financial Parameters ⓘ

	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	TTM
Return on Equity % ⓘ	7.1	3.2	2.4	2.4	0.5	0.6	0	0.1	-46.6	-34	-13.7
Op. Profit Mgn % ⓘ	6.8	1.8	2.6	2.2	27.4	27.8	33.9	25.5	-1886	0	23.9
Net Profit Mgn % ⓘ	5.8	1.6	1.6	1.6	13.9	12.2	1.2	4.3	-12065.2	0	-INF
Debt to Equity ⓘ	0	0	0	0	0	0	0	0	0	0	-
Working Cap Days ⓘ	241	141	201	210	8,799	6,322	11,358	12,876	86,448	0	105
Cash Conv. Cycle ⓘ	154	79	96	97	3,853	1,433	242	636	7,576	0	60

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19
Sales	32.50	56.45	42.17	42.85	1	1.35	0.81	0.56	0.05	0
Operating Expenses ⓘ +	30.29	55.42	41.09	41.89	0.73	0.98	0.53	0.42	1.44	0.55
Manufacturing Costs	0	0	0	0	0	0	0	0	0	0
Material Costs	29.54	54.62	40.33	41.11	0.04	0	0	0	0.70	0
Employee Cost	0.18	0.18	0.18	0.19	0.16	0.23	0.20	0.22	0.11	0.03
Other Costs ⓘ	0.57	0.62	0.59	0.59	0.53	0.75	0.33	0.19	0.63	0.52
Operating Profit ⓘ	2.21	1.03	1.08	0.96	0.28	0.38	0.27	0.14	-1.39	-0.55
Operating Profit Margin (%)	6.8%	1.8%	2.6%	2.2%	27.4%	27.8%	33.8%	25.5%	-2,966.7%	-
Other Income ⓘ +	0.09	0.23	0.18	0.13	0.16	0.07	0.19	0.01	0.49	0.03
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	-5.32	-1.99
Interest ⓘ	0.01	0	0	0	0	0	0	0	0	0
Depreciation ⓘ	0.33	0.39	0.56	0.40	0.29	0.28	0.16	0.11	0.09	0.01
Profit Before Tax ⓘ	1.96	0.87	0.70	0.70	0.14	0.16	0.30	0.04	-6.30	-2.52
Tax ⓘ	0.06	-0	0.03	0	0	-0	0.16	0.01	0.73	-0.02
Profit After Tax	1.90	0.87	0.68	0.70	0.14	0.17	0.14	0.02	-7.03	-2.51
PAT Margin (%)	5.8%	1.6%	1.6%	1.6%	13.9%	12.2%	17.9%	4.5%	-15,011.3%	-
Adjusted EPS (₹)	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-0.3	-0.1
Dividend Payout Ratio (%)	69.80%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Valuation of Adinath Bio-Lab - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19
Equity and Liabilities
Shareholders Fund +	26.79	27.66	28.34	29.04	29.18	29.16	29.30	15.64	8.61	6.10
Share Capital ⓘ	22.07	22.07	22.07	22.07	22.07	22.07	22.07	22.07	22.07	22.07
Reserves ⓘ	4.72	5.59	6.27	6.97	7.11	7.08	7.23	-6.44	-13.47	-15.97
Debt +	0	0	0	0	0	0	0	0	0	0
Long Term Debt	0	0	0	0	0	0	0	0	0	0
Short Term Debt	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	0.19	0.15	0.05	0.03	0.02	0	0	0	0	0
Others Liabilities ⓘ	1.70	0.12	0.13	0.13	0.12	0.16	0.19	0.18	0.94	0.86
Total Liabilities ⓘ	28.69	27.93	28.53	29.20	29.32	29.32	29.49	15.82	9.55	6.96
Fixed Assets
Net Fixed Assets ⓘ +	3.53	2.01	1.86	1.47	1.18	0.71	0.56	0.44	0.26	0.02
Gross Block	4.69	3.39	3.80	3.80	3.80	3.80	3.81	3.81	1.84	0.29
Accumulated Depreciation	1.16	1.38	1.94	2.33	2.62	3.09	3.25	3.37	1.58	0.27
CWIP ⓘ	2.22	2.27	1.87	1.87	1.87	1.87	1.87	1.87	0	0
Investments ⓘ	1.27	1.27	0.56	0.56	2.96	2.96	0.56	0.54	0.03	0.03
Inventories	6.28	3.22	3.15	3.24	3.20	0	0	0.70	0	0
Trade Receivables	7.89	7.29	8.67	7.83	7.02	0.45	0.62	0.62	0.62	0.40
Cash Equivalents	0.21	0.11	0.08	0.08	0.16	0.10	0.08	0.03	0.01	0.02
Others Assets ⓘ	7.29	11.75	12.34	14.16	12.94	23.24	25.81	11.62	8.62	6.48
Total Assets ⓘ	28.69	27.93	28.53	29.20	29.32	29.32	29.49	15.82	9.55	6.96

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19
Cash Flow From Operating Activity ⓘ +	1.05	-1.41	-1.31	-0.13	-0.06	-0.13	-2.60	0.12	-0.54	-0.01
PBT ⓘ	1.96	0.87	0.70	0.70	0.14	0.16	0.30	0.04	-0.98	-0.54
Adjustment ⓘ	0.24	0.16	0.38	0.26	0.13	0.21	-0.03	0.11	0.17	0.44
Changes in Working Capital ⓘ	0.13	-0.83	-2.38	-1.09	-0.34	-0.51	-2.77	-0.02	0.29	0.09
Tax Paid ⓘ	-0.51	-0.06	-0.01	0	0	0	-0.11	0	-0.01	0
Cash Flow From Investing Activity ⓘ +	-0.88	1.31	0.89	0.13	-2.24	0.07	2.58	-0.17	0.52	0.02
Capex	-0.61	1.07	0	-0	-2.40	0	-0.01	0	0.10	0
Net Investments	0	0	0.71	0	0	0	2.40	-0.17	0.40	0
Others ⓘ	-0.27	0.23	0.18	0.13	0.16	0.07	0.19	0	0.03	0.02
Cash Flow From Financing Activity ⓘ +	0	0	0	0	2.38	0	0	0	0	0
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0	0	0	0
Interest Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0	0	0	0	2.38	0	0	0	0	0
Net Cash Flow ⓘ	0.17	-0.10	-0.42	0	0.08	-0.06	-0.02	-0.05	-0.02	0.01

Financial Ratio

PARTICULARS	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19
Ratios
ROE (%)	7.13	3.21	2.43	2.43	0.48	0.57	0.49	0.11	-58.01	-34.08
ROCE (%)	7.39	3.22	2.52	2.43	0.49	0.56	1.04	0.16	-51.97	-34.32
Asset Turnover Ratio	1.15	1.99	1.49	1.48	0.03	0.05	0.03	0.02	0	0
PAT to CFO Conversion(x)	0.55	-1.62	-1.93	-0.19	-0.43	-0.76	-18.57	6	N/A	N/A
Working Capital Days
Receivable Days	86.10	49.10	69.10	70.30	2,698.40	1,007.30	242.20	405.70	4,834	0
Inventory Days	69.50	30.70	27.60	27.20	1,171.90	0	0	460.30	0	0
Payable Days	1.30	1.20	0.90	0.40	273.20	0	0	0	0	0

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Adinath Bio-Lab Ltd FAQs

The current trading price of Adinath Bio-Lab on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Adinath Bio-Lab stood at ₹6.62 Cr

The latest P/E ratio of Adinath Bio-Lab as of 31-Dec-1969 is 0.00.

The latest P/B ratio of Adinath Bio-Lab as of 31-Dec-1969 is 0.23.

The 52-week high of Adinath Bio-Lab is ₹0.30 and the 52-week low is ₹0.30.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Adinath Bio-Lab is ₹0.00 ( Cr.) .

Data is not available for this company.

No data found

About Adinath Bio-Lab Ltd

Adinath Bio Labs is a 27-year old organization, engaged in the manufacture of pharmaceutical raw materials and chemicals for the pharmaceutical and aromatic industries with an excellent track record in the domestic market.

Manufactured from premium quality raw materials, the companyâ€™s products are reputed for their high quality. Adinath Bio-Labs is listed on the Bombay Stock Exchange and the Calcutta Stock Exchange.

The company has established itself as one of the quality manufacturers of natural essential oils and pharmaceutical ingredients.

Adinath Bio-Labs main products in the essential oil division are mentha piperata, spearmint oil, basil oil, clove and eucalyptus oil. The manufacturing plant is situated at the outskirts of Mumbai. It is equipped with facilities for the manufacture of natural menthol and peppermint oil like liquid menthol, mentha oil, natural recryst flakes and crude menthol oil.

Along with menthol crystals, it also produces natural dementholised peppermint oil with the without terpenses as per customer specifications by using its world class fractional distillation columns. These columns are also used to produce terpenes cis-3-hexenol.menthone, liquid menthol as per customerâ€™s requirement.

Products

Mint Products - Under this, Adinath Bio-Labs produces products namely natural menthol BP/USP bold crystals, natural menthol USP medium crystals, natural recryst flakes, natural melted menthol, crude mentha oil natural, liquid menthol, dementholised peppermint oil and peppermint oil.
Essential Oil Products - Under this company produces menthones, Cis-3-Hexenol, mentha piperata natural, spearmint oil-carvone, anethole cis-anethole and basil oil natural.
Other Products - The company manufactures carboxylic acids / dicarboxylic acids, laboratory reagents, morpholine / phenanthroline, quinoline / isoquinolines, phenol / resorcinol / anisole and chemical compounds.

Adinath Bio-Labsâ€™ R&D capability is a vital component for its entire business operations, as it provides a sustainable, long-term and competitive advantage to the company.

Adinath Bio-Lab Ltd (590088)

Adinath Bio-Lab Ltd (590088)

Adinath Bio-Lab stock performance

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Adinath Bio-Lab - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Adinath Bio-Lab Ltd FAQs

About Adinath Bio-Lab Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Adinath Bio-Lab Ltd (590088)

Adinath Bio-Lab Ltd (590088)

Adinath Bio-Lab stock performance

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Adinath Bio-Lab - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Adinath Bio-Lab Ltd FAQs

What is the share price of Adinath Bio-Lab?

What is the market cap of Adinath Bio-Lab?

What is the P/E ratio of Adinath Bio-Lab?

What is the P/B ratio of Adinath Bio-Lab?

What is the 52-week high and low of Adinath Bio-Lab?

What is the TTM revenue of Adinath Bio-Lab?

Is a good quality company?

Is undervalued or overvalued?

Is a good buy now?

About Adinath Bio-Lab Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.